Desh Rakshak Aushdhalaya Ltd () News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{ "main_header": { "sid": 351394, "name": "Desh Rakshak", "stock_name": "Desh Rakshak", "full_name": "Desh Rakshak Aushdhalaya Ltd", "name_url": "stocks-analysis/desh-rakshak", "exchange": 0, "exchangecode": "", "primexch": 0, "country_id": 34, "currency": "INR", "cmp": "23.16", "chg": "0.00", "chgp": "0.00%", "dir": 0, "prev_price": "23.16", "mcapval": "14.00 Cr", "mcap": "Micro Cap", "scripcode": 531521, "symbol": "", "ind_name": "Pharmaceuticals & Biotechnology", "ind_code": 4, "indexname": "", "isin": "INE971E01016", "curr_date": "Mar 04", "curr_time": "", "bse_nse_vol": "800 ", "exc_status": "Active", "traded_date": "Mar 04, 2026", "traded_date_str": "2026 03 04", "score": "", "scoreText": "", "Live": 0, "market_time": 0, "is_blur": 1, "is_blur_class": "blur-registerF-score-header", "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/desh-rakshak-351394-0&utm_source=Spage_Header_Score", "mojoone": { "ismore": 0 } }, "news": { "results": [ { "title": "Desh Rakshak Aushdhalaya Ltd Falls to 52-Week Low Amidst Continued Underperformance", "link": "https://www.marketsmojo.com/news/stocks-in-action/desh-rakshak-aushdhalaya-ltd-falls-to-52-week-low-amidst-continued-underperformance-3869949", "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/DeshRakshakAush_priceRelatedfactors_3869949.png", "date": "2026-03-04 12:44:08", "description": "Desh Rakshak Aushdhalaya Ltd, a player in the Pharmaceuticals & Biotechnology sector, recorded a fresh 52-week low today at Rs.23.16, marking a significant decline amid broader market fluctuations. The stock’s performance continues to trail its sector and benchmark indices, reflecting ongoing pressures on its valuation and financial metrics." }, { "title": "Desh Rakshak Aushdhalaya Ltd Falls 9.74%: 3 Key Factors Driving the Decline", "link": "https://www.marketsmojo.com/news/stocks-in-action/desh-rakshak-aushdhalaya-ltd-falls-974-3-key-factors-driving-the-decline-3862675", "imagepath": "", "date": "2026-02-28 17:02:23", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n <div class=\"highlight-box\">\n <h3>Key Events This Week</h3>\n <p><strong>23 Feb:</strong> Stock hits 52-week low at Rs.25.65 amid market underperformance</p>\n <p><strong>24 Feb:</strong> Downgrade to Strong Sell by MarketsMOJO due to technical weakness and flat financials</p>\n <p><strong>27 Feb:</strong> New 52-week low of Rs.24.37 as selling pressure intensifies</p>\n </div>\n\n <div class=\"stats-row\">\n <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.27.00</div></div>\n <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-value\">Rs.24.37</div><div class=\"stat-change negative\">-9.74%</..." }, { "title": "Desh Rakshak Aushdhalaya Ltd Falls to 52-Week Low Amidst Continued Market Pressure", "link": "https://www.marketsmojo.com/news/stocks-in-action/desh-rakshak-aushdhalaya-ltd-falls-to-52-week-low-amidst-continued-market-pressure-3860346", "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/DeshRakshakAush_priceRelatedfactors_3860346.png", "date": "2026-02-27 12:20:27", "description": "Desh Rakshak Aushdhalaya Ltd, a player in the Pharmaceuticals & Biotechnology sector, touched a new 52-week low of Rs.24.37 on 27 Feb 2026, marking a significant decline amid broader market weakness and sector underperformance." }, { "title": "Desh Rakshak Aushdhalaya Ltd Downgraded to Strong Sell Amid Technical Weakness and Flat Financials", "link": "https://www.marketsmojo.com/news/stock-recommendation/desh-rakshak-aushdhalaya-ltd-downgraded-to-strong-sell-amid-technical-weakness-and-flat-financials-3852368", "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/DeshRakshakAush_mojoScore_3852368.png", "date": "2026-02-24 08:35:20", "description": "Desh Rakshak Aushdhalaya Ltd, a player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating downgraded from Sell to Strong Sell as of 23 February 2026. This revision reflects deteriorating technical indicators, a cautious financial trend, and a nuanced valuation profile, signalling heightened risks for investors despite some attractive valuation metrics." }, { "title": "Desh Rakshak Aushdhalaya Ltd Hits 52-Week Low Amidst Market Underperformance", "link": "https://www.marketsmojo.com/news/stocks-in-action/desh-rakshak-aushdhalaya-ltd-hits-52-week-low-amidst-market-underperformance-3851419", "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/DeshRakshakAush_priceRelatedfactors_3851419.png", "date": "2026-02-23 10:46:04", "description": "Desh Rakshak Aushdhalaya Ltd, a player in the Pharmaceuticals & Biotechnology sector, recorded a fresh 52-week low today, with its stock price falling to Rs. 25.65. This marks a significant decline amid a broader market environment where the Sensex continues to show resilience." }, { "title": "Desh Rakshak Aushdhalaya Ltd Valuation Shifts Signal Renewed Price Attractiveness", "link": "https://www.marketsmojo.com/news/stocks-in-action/desh-rakshak-aushdhalaya-ltd-valuation-shifts-signal-renewed-price-attractiveness-3846210", "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/DeshRakshakAush_valuationdot_3846210.png", "date": "2026-02-19 08:00:24", "description": "Desh Rakshak Aushdhalaya Ltd has witnessed a notable improvement in its valuation parameters, shifting from a very attractive to an attractive rating. This change reflects a recalibration of its price-to-earnings (P/E) and price-to-book value (P/BV) ratios relative to historical levels and peer benchmarks, signalling a potential opportunity for investors amid a challenging sector backdrop." }, { "title": "Are Desh Rakshak Aushdhalaya Ltd latest results good or bad?", "link": "https://www.marketsmojo.com/news/result-analysis/are-desh-rakshak-aushdhalaya-ltd-latest-results-good-or-bad-3840602", "imagepath": "", "date": "2026-02-14 19:58:37", "description": "Desh Rakshak Aushdhalaya Ltd's latest financial results for Q3 FY26 reflect ongoing operational challenges, characterized by significant revenue volatility and compressed profitability margins. The company reported net sales of ₹1.40 crores, which, while showing a sequential increase of 47.37% from the previous quarter, represents a year-on-year decline of 25.53% compared to ₹1.88 crores in Q3 FY25. This pattern of fluctuating sales raises concerns about demand stability and operational execution.\n\nNet profit for the quarter stood at ₹0.09 crores, flat sequentially but down 25% year-on-year from ₹0.12 crores in Q3 FY25. The profit after tax (PAT) margin slightly compressed to 6.43%, indicating difficulties in translating top-line growth into bottom-line expansion. Operating margins improved to 17.86% from 15.43% in the previous year, but this was a decline from 27.37% in the prior quarter, highlighting the ..." }, { "title": "Desh Rakshak Aushdhalaya Drops 15.91% Amid Valuation Shift and Q3 Margin Pressure", "link": "https://www.marketsmojo.com/news/stocks-in-action/desh-rakshak-aushdhalaya-drops-1591-amid-valuation-shift-and-q3-margin-pressure-3840225", "imagepath": "", "date": "2026-02-14 17:17:33", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n <div class=\"highlight-box\">\n <h3>Key Events This Week</h3>\n <p><strong>Feb 9:</strong> Stock opens at Rs.31.30, down 2.19% amid broad market gains</p>\n <p><strong>Feb 10:</strong> Valuation upgrade highlights improved price attractiveness</p>\n <p><strong>Feb 13:</strong> Q3 FY26 results reveal revenue volatility and margin pressure</p>\n <p><strong>Feb 13:</strong> Week closes at Rs.26.91, down 15.91% for the week</p>\n </div>\n\n <div class=\"stats-row\">\n <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.32.00</div></div>\n <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div cla..." }, { "title": "Desh Rakshak Aushdhalaya Q3 FY26: Revenue Volatility and Margin Pressure Cloud Outlook", "link": "https://www.marketsmojo.com/news/result-analysis/desh-rakshak-aushdhalaya-q3-fy26-revenue-volatility-and-margin-pressure-cloud-outlook-3838686", "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/DeshRakshakAush_quaterlyResult_3838686.png", "date": "2026-02-13 21:07:00", "description": "Desh Rakshak Aushdhalaya Ltd., one of India's oldest manufacturers of pure Ayurvedic and herbal products, reported its third-quarter FY2026 results with net profit of ₹0.09 crores, unchanged sequentially but declining 25.00% year-on-year. With a micro-cap market capitalisation of just ₹16.00 crores, the century-old Haridwar-based company continues to grapple with revenue volatility and operational challenges that have weighed on investor sentiment." } ], "total": 203, "sid": "351394", "stock_news_url": "https://www.marketsmojo.com/news/desh-rakshak-aushdhalaya-351394" }, "announcements": [ { "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication", "datetime": "14-Feb-2026", "details": "The Company hereby submit Newspaper publication of Financial Results for the quarter and nine months ended December 31 2025", "source": "BSE" }, { "caption": "Board Meeting Outcome for Outcome Of Board Meeting Held On Friday 13Th Day Of February 2026 Meeting Commenced At 01:00 P.M. And Concluded At 02:00 P.M Pursuant To Para A Of Part A Of Schedule III And Regulation 30 Of The SEBI (LODR) Regulations 2015", "datetime": "13-Feb-2026", "details": "With reference to the captioned subject the company hereby inform that the Board of Directors of the Company in its meeting held on Friday 13th day of February 2026 has discussed considered and took noted and approved the following matters: 1.All the directors of the Company duly presented in the meeting and hence there was no leave of absence granted. 2.Took noted the minutes of the previous meeting of Board of Directors of the Company. 3. Considered and Approved the Un-Audited Financial Results for the quarter and nine months ended 31st day of December 2025. 4.Considered took noted and Approved the Limited Review Report on the financial results for the quarter and nine months ended 31st day of December 2025. 5.Took noted of the Closure of Trading window. 6.Considered took noted and Approved statement confirming that there is no deviation or variation in the use of the proceeds and the utilisation of fund.", "source": "BSE" }, { "caption": "Statement Of No Deviation(S) Or Variation(S) In The Use Of Proceeds And Utilization Of Funds Relating To Allotment Of Equity Shares On Preferential Basis Under Regulation 32 Of The SEBI (LODR) Regulations 2015", "datetime": "13-Feb-2026", "details": "Statement of no deviation or variation as per Regulation 32 of the SEBI (LODR) Regulations 2015", "source": "BSE" } ], "corporate_actions": [ { "img": "board-meeting.svg", "title": "BOARD MEETING", "msg": "<span>No</span> Upcoming Board Meetings", "data": [] }, { "img": "dividend.svg", "title": "DIVIDEND", "msg": "No <strong>Dividend</strong> history available", "data": [] }, { "img": "splits.svg", "title": "SPLITS", "msg": "No <strong>Splits</strong> history available", "data": [] }, { "img": "bonus.svg", "title": "BONUS", "msg": "No <strong>Bonus</strong> history available", "data": [] }, { "img": "rights-issues.svg", "title": "RIGHTS", "msg": "No <strong>Rights</strong> history available", "data": [] } ] }

Key Events This Week

23 Feb: Stock hits 52-week low at Rs.25.65 amid market underperformance

24 Feb: Downgrade to Strong Sell by MarketsMOJO due to technical weakness and flat financials

27 Feb: New 52-week low of Rs.24.37 as selling pressure intensifies

-9.74%Read full news article

Desh Rakshak Aushdhalaya Ltd Falls to 52-Week Low Amidst Continued Market Pressure

2026-02-27 12:20:27

Desh Rakshak Aushdhalaya Ltd, a player in the Pharmaceuticals & Biotechnology sector, touched a new 52-week low of Rs.24.37 on 27 Feb 2026, marking a significant decline amid broader market weakness and sector underperformance.

Read full news article

Desh Rakshak Aushdhalaya Ltd Downgraded to Strong Sell Amid Technical Weakness and Flat Financials

2026-02-24 08:35:20

Desh Rakshak Aushdhalaya Ltd, a player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating downgraded from Sell to Strong Sell as of 23 February 2026. This revision reflects deteriorating technical indicators, a cautious financial trend, and a nuanced valuation profile, signalling heightened risks for investors despite some attractive valuation metrics.

Read full news article

Desh Rakshak Aushdhalaya Ltd Hits 52-Week Low Amidst Market Underperformance

2026-02-23 10:46:04

Desh Rakshak Aushdhalaya Ltd, a player in the Pharmaceuticals & Biotechnology sector, recorded a fresh 52-week low today, with its stock price falling to Rs. 25.65. This marks a significant decline amid a broader market environment where the Sensex continues to show resilience.

Read full news article

Desh Rakshak Aushdhalaya Ltd Valuation Shifts Signal Renewed Price Attractiveness

2026-02-19 08:00:24

Desh Rakshak Aushdhalaya Ltd has witnessed a notable improvement in its valuation parameters, shifting from a very attractive to an attractive rating. This change reflects a recalibration of its price-to-earnings (P/E) and price-to-book value (P/BV) ratios relative to historical levels and peer benchmarks, signalling a potential opportunity for investors amid a challenging sector backdrop.

Read full news article

Are Desh Rakshak Aushdhalaya Ltd latest results good or bad?

2026-02-14 19:58:37

Desh Rakshak Aushdhalaya Ltd's latest financial results for Q3 FY26 reflect ongoing operational challenges, characterized by significant revenue volatility and compressed profitability margins. The company reported net sales of ₹1.40 crores, which, while showing a sequential increase of 47.37% from the previous quarter, represents a year-on-year decline of 25.53% compared to ₹1.88 crores in Q3 FY25. This pattern of fluctuating sales raises concerns about demand stability and operational execution. Net profit for the quarter stood at ₹0.09 crores, flat sequentially but down 25% year-on-year from ₹0.12 crores in Q3 FY25. The profit after tax (PAT) margin slightly compressed to 6.43%, indicating difficulties in translating top-line growth into bottom-line expansion. Operating margins improved to 17.86% from 15.43% in the previous year, but this was a decline from 27.37% in the prior quarter, highlighting the ...

Read full news article

Desh Rakshak Aushdhalaya Drops 15.91% Amid Valuation Shift and Q3 Margin Pressure

2026-02-14 17:17:33

Key Events This Week

Feb 9: Stock opens at Rs.31.30, down 2.19% amid broad market gains

Feb 10: Valuation upgrade highlights improved price attractiveness

Feb 13: Q3 FY26 results reveal revenue volatility and margin pressure

Feb 13: Week closes at Rs.26.91, down 15.91% for the week

Week Open

Rs.32.00

Week Close

Read full news article

Desh Rakshak Aushdhalaya Q3 FY26: Revenue Volatility and Margin Pressure Cloud Outlook

2026-02-13 21:07:00

Desh Rakshak Aushdhalaya Ltd., one of India's oldest manufacturers of pure Ayurvedic and herbal products, reported its third-quarter FY2026 results with net profit of ₹0.09 crores, unchanged sequentially but declining 25.00% year-on-year. With a micro-cap market capitalisation of just ₹16.00 crores, the century-old Haridwar-based company continues to grapple with revenue volatility and operational challenges that have weighed on investor sentiment.

Read full news article

View All News